Johnson & Johnson under pressure as FDA approves new use for Xarelto

Johnson & Johnson shares were flat in trading Monday as legal troubles clouded its financial outlook.
https://ift.tt/2VHD0bo
Home » Fox » Johnson & Johnson under pressure as FDA approves new use for Xarelto
By spyke_spurs • October 14, 2019 • Fox • Comments : 0

Ripple Prime CEO Mike Higgins reveals XRP's growing role as collateral in institutional finance, alongside Bitcoin and Ethereum , ami...
Post a Comment